Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Nasdaq:BXRX
MALVERN, Pa., April 03, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced...

